Search Results for "itraconazole"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for itraconazole. Results 11 to 20 of 79 total matches.
See also: Sporanox

Drug Interactions

   
The Medical Letter on Drugs and Therapeutics • Jun 08, 2003  (Issue 1158)
being substrates of the enzyme may be more important clinically. Itraconazole (Sporanox), for example ...
Changes caused by one drug in the absorption, distribution, metabolism or excretion of another may lead to a pharmacokinetic adverse drug interaction (DN Juurlink et al, JAMA 2003; 289:1652). Additive drug interactions, such as vasodilation caused by both sildenafil (Viagra) and nitrates, can also have adverse effects.
Med Lett Drugs Ther. 2003 Jun 8;45(1158):46-8 |  Show IntroductionHide Introduction

Ciclopirox (Penlac) Nail Lacquer for Onychomycosis

   
The Medical Letter on Drugs and Therapeutics • Jun 12, 2000  (Issue 1080)
infections of the nails are generally resistant to topical treatment. Terbinafine (Lamisil), itraconazole ...
Ciclopirox nail lacquer (Penlac - Dermik) has been approved by the FDA for treatment of mild-to-moderate onychomycosis due to Trichophyton rubrum, without involvement of the lunula. The drug has been available for many years as a lotion and cream (Loprox) for treatment of cutaneous fungal infection
Med Lett Drugs Ther. 2000 Jun 12;42(1080):51-2 |  Show IntroductionHide Introduction

PDE5 Inhibitors for Erectile Dysfunction

   
The Medical Letter on Drugs and Therapeutics • Feb 06, 2012  (Issue 1383)
, itraconazole, ketoconazole, nefazodone, nelfinavir, posaconazole, ritonavir, telaprevir, telithromycin ...
Sildenafil (Viagra), tadalafil (Cialis) and vardenafil (Levitra, Staxyn) have become the standard treatment for erectile dysfunction. Head-to-head comparisons of these agents are still lacking, but some differences between them and new recommendations for their dosing (see Table 2) are worth noting.
Med Lett Drugs Ther. 2012 Feb 6;54(1383):10-1 |  Show IntroductionHide Introduction

Eplerenone (Inspra)

   
The Medical Letter on Drugs and Therapeutics • May 12, 2003  (Issue 1156)
such as ketoconazole (Nizoral), itraconazole (Sporanox), erythromycin, ritonavir (Norvir) or verapamil (Calan ...
Eplerenone (e pler' en one; Inspra - Pharmacia), an aldosterone receptor antagonist similar to spironolactone (Aldactone, and others), has been approved by the FDA, but not yet marketed, for treatment of hypertension. It has also been tried for treatment of heart failure.
Med Lett Drugs Ther. 2003 May 12;45(1156):39-40 |  Show IntroductionHide Introduction

Vardenafil (Levitra) for Erectile Dysfunction

   
The Medical Letter on Drugs and Therapeutics • Sep 29, 2003  (Issue 1166)
of erythromycin or 200 mg of ketoconazole (Nizoral) or itraconazole (Sporanox), 2.5 mg per day with indinavir ...
Vardenafil (Levitra -Bayer) is the second oral drug approved by the FDA for treatment of erectile dysfunction. Sildenafil (Viagra - Medical Letter 1998; 40:51), the first oral drug, has been available for 5 years. Pharmacokinetics, effectiveness, adverse effects, dosage and cost of the new drug are reviewed. Whether it offers any benefits over sildenafil is discussed.
Med Lett Drugs Ther. 2003 Sep 29;45(1166):77-8 |  Show IntroductionHide Introduction

Table: Inhibitors and Inducers of CYP Enzymes, P-Glycoprotein, and Other Transporters (online only)

   
The Medical Letter on Drugs and Therapeutics • Feb 06, 2023  (Issue 1669)
imatinib indinavir isoniazid itraconazole ketoconazole lopinavir/ritonavir nefazodone nelfinavir ...
View the Inhibitors and Inducers of CYP Enzymes, P-Glycoprotein, and Other Transporters tables
Med Lett Drugs Ther. 2023 Feb 6;65(1669):e28-30   doi:10.58347/tml.2023.1669g |  Show IntroductionHide Introduction

Fexofenadine

   
The Medical Letter on Drugs and Therapeutics • Oct 25, 1996  (Issue 986)
of terfenadine and astemizole enough to cause arrhythmias include ketoconazole (Nizoral), itraconazole (Sporanox ...
Fexofenadine (fex oh fen' a deen) hydrochloride (Allegra - Hoechst Marion Roussel) has been approved by the US Food and Drug Administration for treatment of seasonal allergic rhinitis. An active metabolite of terfenadine, fexofenadine is being heavily advertised as "nonsedating...without 'black box' warnings."
Med Lett Drugs Ther. 1996 Oct 25;38(986):95-6 |  Show IntroductionHide Introduction

Sildenafil: An Oral Drug for Impotence

   
The Medical Letter on Drugs and Therapeutics • May 08, 1998  (Issue 1026)
) inhibit CYP3A4, decrease metabolism of sildenafil and may increase plasma concentrations. Itraconazole ...
Sildenafil citrate (Viagra - Pfizer) is the first oral drug approved by the FDA for treatment of erectile dysfunction. Alprostadil is also marketed for this indication but must be injected into the corpus cavemosum (Caverject) or pushed into the urethra (MUSE).
Med Lett Drugs Ther. 1998 May 8;40(1026):51-2 |  Show IntroductionHide Introduction

New Advertisement for An Old Antihistamine

   
The Medical Letter on Drugs and Therapeutics • Jan 22, 1993  (Issue 888)
, or concurrent use of erythromycin, troleandomycin (TAO), ketoconazole (Nizoral), or itraconazole (Sporanox ...
Advertisements for clemastine (Tavist-1 - Sandoz), an ethanolamine oral antihistamine, have recently appeared on television and in major newspapers in the USA. Clemastine is an old drug (Medical Letter, 21:24, 1979) that has now become available without a prescription.
Med Lett Drugs Ther. 1993 Jan 22;35(888):9-10 |  Show IntroductionHide Introduction

Topical Terbinafine for Tinea Infections

   
The Medical Letter on Drugs and Therapeutics • Aug 20, 1993  (Issue 903)
(Nizoral) or itraconazole (Sporanox), but no correlation has been established between in vitro activity ...
Terbinafine 1% cream (Lamisil - Sandoz), an allylamine synthetic antifungal drug chemically related to naftifine (Naftin - Medical Letter, 30:98, 1988), is now available in the USA for topical treatment of tinea pedis, tinea cruris, and tinea corporis infections. An oral formulation is available in Europe and is under investigation here.
Med Lett Drugs Ther. 1993 Aug 20;35(903):76-8 |  Show IntroductionHide Introduction